Noam Gavriely
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Noam Gavriely has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
David W. Cugell
Northwestern University Medical School
1 shared publicationGiora Rosenhouse
Faculty of Civil Engineering, Technion
1 shared publicationL. Bentur
Division of Paediatric Pulmonology, Rambam Medical Centre, Haifa, Israel
1 shared publication- Marwan Shinawi
Division of Genetics and Genomics Medicine Washington University School of Medicine St. Louis Missouri USA
1 shared publication Muhammad Mahagnah
Bruce Rappaport Faculty of Medicine and the Rappaport Institute, Technion
1 shared publicationR. Beck
1 shared publication
Latest Publications
- 1 October 2005
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 33 (10) , 1344-1351
Measurements and Theory of Normal Tracheal Breath Sounds
We studied the mechanisms by which turbulent flow induces tracheal wall vibrations detected as tracheal breath sounds (TRBSs). The effects of flow rate at transitional Reynold's numbers (1300–10,000) and gas density on spectral patterns of TRBSs in eight normal subjects were measured. TRBSs were recorded with a contact sensor during air and heliox breathing at four flow rates (1.0, 1.5, 2.0, and 2.5 l/s). We found that normalized TRBSs were proportional to flow to the 1.89 power during inspiration and to the 1.59 power during expiration irrespective of gas density. The amplitude of TRBSs with heliox was lower than with air by a factor of 0.33 ± 0.12 and 0.44 ± 0.16 during inspiration and expiration, respectively. The spectral resonance frequencies were higher during heliox than air breathing by a factor of 1.75 ± 0.2—approximately the square root of the reciprocal of the air/heliox wave propagation speed ratio. In conclusion, the flow-induced pressure fluctuations inside the trachea, which cause tracheal wall vibrations, were detected as TRBSs consist of two components: (1) a dominant local turbulent eddy component whose amplitude is proportional to the gas density and nonlinearly related to the flow; and (2) a propagating acoustic component with resonances whose frequencies correspond to the length of the upper airway and to the free-field sound speed. Therefore, TRBSs consist primarily of direct turbulent eddy pressure fluctuations that are perceived as sound during auscultation.
- 1 October 2005
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 33 (10) , 1344-1351
Measurements and Theory of Normal Tracheal Breath Sounds
We studied the mechanisms by which turbulent flow induces tracheal wall vibrations detected as tracheal breath sounds (TRBSs). The effects of flow rate at transitional Reynold's numbers (1300–10,000) and gas density on spectral patterns of TRBSs in eight normal subjects were measured. TRBSs were recorded with a contact sensor during air and heliox breathing at four flow rates (1.0, 1.5, 2.0, and 2.5 l/s). We found that normalized TRBSs were proportional to flow to the 1.89 power during inspiration and to the 1.59 power during expiration irrespective of gas density. The amplitude of TRBSs with heliox was lower than with air by a factor of 0.33 ± 0.12 and 0.44 ± 0.16 during inspiration and expiration, respectively. The spectral resonance frequencies were higher during heliox than air breathing by a factor of 1.75 ± 0.2—approximately the square root of the reciprocal of the air/heliox wave propagation speed ratio. In conclusion, the flow-induced pressure fluctuations inside the trachea, which cause tracheal wall vibrations, were detected as TRBSs consist of two components: (1) a dominant local turbulent eddy component whose amplitude is proportional to the gas density and nonlinearly related to the flow; and (2) a propagating acoustic component with resonances whose frequencies correspond to the length of the upper airway and to the free-field sound speed. Therefore, TRBSs consist primarily of direct turbulent eddy pressure fluctuations that are perceived as sound during auscultation.
- 1 April 2003
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 21 (4) , 621-626
Wheeze monitoring in children for assessment of nocturnal asthma and response to therapy
The utilisation of nocturnal wheeze monitoring and quantification for assessment of asthma activity was studied in symptomatic school-aged children before and during treatment.Twelve children 6–14 yrs of age with mild or moderate untreated asthma were studied at home three times: before, 48 h and 6 weeks into treatment with 5 mg montelukast daily. Lung sounds were recorded overnight by an automatic wheeze detection device (PulmoTrack®). Per cent wheezing within each respiratory cycle was calculated every 30 s throughout the night and a Nocturnal Wheeze Index (NWI) was calculated for the total night. The results were compared with spirometric indices (forced expiratory volume in one second (FEV1), forced vital capacity), bronchial reactivity (provocative concentration causing a 20% fall in FEV1by adenosine 5′-monophosphate (PC20)) and daily symptom scores, performed in parallel at each stage of the study.The pretreatment NWI was 814±898 (mean±sd), which declined to 318±199 2 days after onset, and to 137±101 after 6 weeks of treatment. The NWI in seven healthy children was 47±43. The FEV1, PC20and symptom scores improved in parallel.Wheeze monitoring provides quantitative and noninvasive information about the extent of nocturnal wheezing in children, correlates well with conventional indices of asthma activity and can assist in assessing efficacy of treatment.
- 1 April 2003
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 21 (4) , 621-626
Wheeze monitoring in children for assessment of nocturnal asthma and response to therapy
The utilisation of nocturnal wheeze monitoring and quantification for assessment of asthma activity was studied in symptomatic school-aged children before and during treatment.Twelve children 6–14 yrs of age with mild or moderate untreated asthma were studied at home three times: before, 48 h and 6 weeks into treatment with 5 mg montelukast daily. Lung sounds were recorded overnight by an automatic wheeze detection device (PulmoTrack®). Per cent wheezing within each respiratory cycle was calculated every 30 s throughout the night and a Nocturnal Wheeze Index (NWI) was calculated for the total night. The results were compared with spirometric indices (forced expiratory volume in one second (FEV1), forced vital capacity), bronchial reactivity (provocative concentration causing a 20% fall in FEV1by adenosine 5′-monophosphate (PC20)) and daily symptom scores, performed in parallel at each stage of the study.The pretreatment NWI was 814±898 (mean±sd), which declined to 318±199 2 days after onset, and to 137±101 after 6 weeks of treatment. The NWI in seven healthy children was 47±43. The FEV1, PC20and symptom scores improved in parallel.Wheeze monitoring provides quantitative and noninvasive information about the extent of nocturnal wheezing in children, correlates well with conventional indices of asthma activity and can assist in assessing efficacy of treatment.